Diabetes
From the Journals
Endocrine Society advises on diabetes care for older adults
A clinical practice guideline from the Endocrine Society addresses the impact of aging on patients with diabetes aged 65 years and older.
From the Journals
No increase in UTI risk with SGLT-2 inhibitors
compared...
News
FDA approves Baqsimi nasal powder for emergency hypoglycemia treatment
It is the first glucagon therapy approved for this indication that is administrable without an injection.
From the Journals
Inadequate glycemic control in type 1 diabetes leads to increased fracture risk
Each percentage increase in hemoglobin level was associated with a 7% increase in fracture risk.
Conference Coverage
DECLARE-TIMI58 shows improved kidney function with dapagliflozin
SAN FRANCISCO – The SGLT2 dapagliflozin was better than placebo at slowing down kidney disease in patients with type 2 diabetes
From the Journals
Plant-based foods could keep type 2 diabetes at bay
Meta-analysis suggests diets high in nonanimal foods may significantly lower risk.
News
FDA declines dapagliflozin indication as adjunct for type 1 diabetes
AstraZeneca says it has received a complete response letter, but gives no reason for the agency’s decision.
Conference Coverage
CARMELINA confirms linagliptin’s renal, CV safety, but it’s still third-line for type 2 diabetes
SAN FRANCISCO – The study was unusual among other DPP-4 trials in that almost 60% of the patients were older than 65, and 62.3% had impaired renal...
Latest News
The costs and benefits of SGLT2 inhibitors & GLP-1 RAs
The price tags on these drugs are the biggest barrier to their use.
Latest News
BMI screening trigger for type 2 diabetes is unreliable for at-risk black, Hispanic adults
SAN FRANCISCO – One risk factor should trigger screening in normal weight.
Latest News
Low-fat dairy associated with decreased risk of type 2 diabetes
SAN FRANCISCO – An indicator of healthy living, or a true effect?